CARLA MENDIETA: Open Payments
NPI 1407522303 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,229 in 65 payments from 15 companies in 2025. Trend: 2023 $881 · 2024 $799 · 2025 $1,229
Food & beverage: $1,197Education: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $337 |
| ABBVIE INC. | 11 | $202 |
| Novo Nordisk Inc | 6 | $118 |
| Amgen Inc. | 6 | $97 |
| PFIZER INC. | 5 | $83 |
| Exact Sciences Corporation | 4 | $71 |
| Antares Pharma, Inc. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
Products named: AIRSUPRA, BREZTRI, QULIPTA, OTEZLA, VRAYLAR, NURTEC ODT, UBRELVY, XYOSTED.
Industry payments across AR — which companies pay providers there.
